New test can help doctors choose best treatment for ovarian cancer
Researchers have devised a new test to help doctors diagnose ovarian tumours and choose the most appropriate treatment.
Oct 16, 2014
0
0
Researchers have devised a new test to help doctors diagnose ovarian tumours and choose the most appropriate treatment.
Oct 16, 2014
0
0
An interdisciplinary team of researchers from the University of Vienna (Institute of Inorganic Chemistry) and the Medical University of Vienna (Institute for Cancer Research) has successfully developed a new strategy for ...
Sep 26, 2014
0
0
UPV/EHU researchers have developed a method for the diagnosis and prognosis of cutaneous melanoma, the type of skin cancer with the highest mortality rate.This method will help not only in the more effective early detection ...
Feb 19, 2014
0
0
Despite the fact that the cure rate for breast cancer, the most common cancer in women, is very high (around 80%), this disease can nevertheless have very serious consequences. The majority of breast cancer-related deaths ...
Nov 12, 2013
0
0
Researchers at A*STAR's Singapore Immunology Network (SIgN) have discovered a new mechanism involving p53, the famous tumour suppressor, to fight against aggressive cancers. This strategy works by sabotaging the ability of ...
Sep 18, 2013
0
0
Researchers from the Centre for Genomic Regulation (CRG) in Barcelona reprogramme lymphoma and leukaemia cells to halt their malignancy. Resulting cells remain benign even when no longer subjected to treatment and reduce ...
Apr 3, 2013
0
0
Tumour cells need far more nutrients than normal cells and these nutrients cannot get into the malignant cells without transporters.
Jan 24, 2013
0
0
For patients in whom a recurrence of bowel cancer is suspected, the study data currently available allow no robust conclusions as to the advantages and disadvantages of using positron emission tomography (PET), alone or in ...
Dec 10, 2012
0
0
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively ...
Dec 5, 2012
0
0
A newly developed antibody targeting a signalling pathway that is frequently active in solid tumours has shown encouraging signs of efficacy in its first trial in humans, researchers will report at the 24th EORTC-NCI-AACR ...
Nov 6, 2012
0
0